Standardization of steroid receptor assays in human breast cancer—IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays-Reference-Cited by-同舟云学术

Standardization of steroid receptor assays in human breast cancer—IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays

Published:1986-08 Issue:8 Volume:22 Page:945-952
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Koenders A,Thorpe S.M

Publisher

Elsevier BV

Subject

Oncology

Reference19 articles.

1. Prediction of hormone dependence in human breast cancer;Jensen,1975

2. Oestrogen receptors and prognosis in early breast cancer;Cooke;The Lancet,1979

3. The value of estrogen and progesterone receptors in the treatment of breast cancer;Osborne;Cancer,1980

4. Oestrogen receptors and survival in early breast cancer;Croton;Br Med J,1981

5. Steroid receptors and prognosis in operable (Stage I and II) breast cancer;Stewart;Eur J Cancer Clin Oncol,1983

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two Years of Adjuvant Tamoxifen Provides a Survival Benefit Compared With No Systemic Treatment in Premenopausal Patients With Primary Breast Cancer: Long-Term Follow-Up (> 25 years) of the Phase III SBII:2pre Trial;Journal of Clinical Oncology;2016-07-01

2. A nomogram predicting the probability of primary breast cancer survival at 2- and 5-years using pathological and biological tumor parameters;Journal of Surgical Oncology;2011-05-04

3. Messenger RNA Expression of Leptin and Leptin Receptors and their Prognostic Value in 322 Human Primary Breast Cancers;Clinical Cancer Research;2006-04-01

4. TReP-132 Controls Cell Proliferation by Regulating the Expression of the Cyclin-Dependent Kinase Inhibitors p21 WAF1/Cip1 and p27 Kip1;Molecular and Cellular Biology;2005-06

5. Prognostic Value of ERM Gene Expression in Human Primary Breast Cancers;Clinical Cancer Research;2004-11-01